Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease

被引:30
|
作者
Si, Xiaoli [1 ,2 ]
Dai, Shaobing [3 ]
Fang, Yi [1 ]
Tang, Jiahui [1 ]
Wang, Zhiyun [1 ]
Li, Yaolin [1 ]
Song, Zhe [1 ]
Chen, Ying [1 ]
Liu, Yi [1 ]
Zhao, Guohua [1 ,2 ,4 ]
Zhang, Baorong [1 ]
Pu, Jiali [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 4, Int Inst Med, Sch Med,Dept Neurol, Yiwu 322000, Zhejiang, Peoples R China
[3] Zhejiang Univ, Womens Hosp, Sch Med, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Neurol, N1 Ave, Yiwu 322000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Glymphatic system; Aquaporin-4; Matrix metalloproteinase-9; Metabolomics; BETA-DYSTROGLYCAN; SUBSTANTIA-NIGRA; ALPHA; MODEL;
D O I
10.1016/j.jare.2023.03.004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: The glymphatic system offers a perivascular pathway for the clearance of pathological proteins and metabolites to optimize neurological functions. Glymphatic dysfunction plays a pathogenic role in Parkinson's disease (PD); however, the molecular mechanism of glymphatic dysfunction in PD remains elusive. Objective: To explore whether matrix metalloproteinase-9 (MMP-9)-mediated 13-dystroglycan (13 -DG) cleavage is involved in the regulation of aquaporin-4 (AQP4) polarity-mediated glymphatic system in PD. Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD and A53T mice were used in this study. The glymphatic function was evaluated using ex vivo imaging. TGN-020, an AQP4 antagonist, was administered to investigate the role of AQP4 in glymphatic dysfunction in PD. GM6001, an MMP-9 antagonist, was administered to investigate the role of the MMP-9/13-DG pathway in regulating AQP4. The expression and distribution of AQP4, MMP-9, and 13 -DG were assessed using western blotting, immunofluorescence, and co-immunoprecipitation. The ultrastructure of basement membrane (BM)astrocyte endfeet was detected using transmission electron microscopy. Rotarod and open-field tests were performed to evaluate motor behavior. Results: Perivascular influx and efflux of cerebral spinal fluid tracers were reduced in MPTP-induced PD mice with impaired AQP4 polarization. AQP4 inhibition aggravated reactive astrogliosis, glymphatic drainage restriction, and dopaminergic neuronal loss in MPTP-induced PD mice. MMP-9 and cleaved 0 -DG were upregulated in both MPTP-induced PD and A53T mice, with reduced polarized localization of 0DG and AQP4 to astrocyte endfeet. MMP-9 inhibition restored BM-astrocyte endfeet-AQP4 integrity and attenuated MPTP-induced metabolic perturbations and dopaminergic neuronal loss. Conclusion: AQP4 depolarization contributes to glymphatic dysfunction and aggravates PD pathologies, and MMP-9-mediated 0 -DG cleavage regulates glymphatic function through AQP4 polarization in PD, which may provide novel insights into the pathogenesis of PD. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:125 / 136
页数:12
相关论文
共 50 条
  • [1] Matrix metalloproteinase-9 promotes depolarization-mediated retinal degeneration
    Mali, RS
    Cheng, M
    Chintala, SK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [2] Enterovirus 71 infection induced Aquaporin-4 depolarization by increasing matrix metalloproteinase-9 activity
    Wang, Huanru
    Yuan, Meng
    Yang, Enhui
    Chen, Deyan
    Su, Airong
    Wu, Zhiwei
    NEUROSCIENCE LETTERS, 2021, 759
  • [3] Investigating the Role of Aquaporin-4 Mediated Glymphatic Clearance in Parkinson's Disease
    Llewellyn, Sophie K.
    Lopes, Douglas M.
    Gentleman, Steve M.
    Schapira, Anthony H. V.
    Lythgoe, Mark F.
    Harrison, Ian F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2025, 51
  • [4] Matrix Metalloproteinase-9 and Its Involvement in Parkinson's Disease
    Kumari, Ruchi
    Verma, Aanchal
    Dubey, Nandini
    Agrawal, Anant
    NEUROCHEMICAL JOURNAL, 2023, 17 (02) : 236 - 242
  • [5] Matrix Metalloproteinase-9 and Its Involvement in Parkinson’s Disease
    Ruchi Ahsas Goyal
    Aanchal Kumari
    Nandini Verma
    Anant Dubey
    Neurochemical Journal, 2023, 17 : 236 - 242
  • [6] Aquaporin-4 and Parkinson's Disease
    Lapshina, Ksenia V.
    Ekimova, Irina V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [7] Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics
    Prathipati, Priyanka
    Metreveli, Naira
    Nandi, Shyam Sundar
    Tyagi, Suresh C.
    Mishra, Paras K.
    FRONTIERS IN PHYSIOLOGY, 2016, 7
  • [8] Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson's Disease
    Fang, Yi
    Dai, Shaobing
    Jin, Chongyao
    Si, Xiaoli
    Gu, Luyan
    Song, Zhe
    Gao, Ting
    Chen, Ying
    Yan, Yaping
    Yin, Xinzhen
    Pu, Jiali
    Zhang, Baorong
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 13
  • [9] Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4
    Wang, Xiaoyin
    Zhang, Junhe
    Yang, Yuxin
    Dong, Weihua
    Wang, Fang
    Wang, Li
    Li, Xiaojuan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (01) : 263 - 267
  • [10] Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury
    Kim, Je Hyeong
    Suk, Min Hyun
    Yoon, Dae Wui
    Lee, Seung Heon
    Hur, Gyu Young
    Jung, Ki Hwan
    Jeong, Hae Cheol
    Lee, Sung Yong
    Lee, Sang Yeub
    Suh, In Bum
    Shin, Chol
    Shim, Jae Jeong
    In, Kwang Ho
    Yoo, Se Hwa
    Kang, Kyung Ho
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2006, 291 (04) : L580 - L587